14/15 July 2020
GMP News No. 596
1 September 2005
New EMEA Guideline on Plastic Packaging Materials
On 1 December 2005 the Guideline on Plastic Immediate Packaging Materials published by EMEA will come into force and thus replace the former Guideline on Plastic Primary Packaging Materials 3AQ10a.
This guideline describes which data regarding plastic immediate packaging materials have to be handed in together with the dossier for the marketing approval of an API or medicinal product. The term "immediate" refers to those materials that are in direct contact with the API or medicinal product.
This guideline does not refer retrospectively to products that are already on the market. However, the requirements laid down in this guideline have to be observed in case of a variation (i.e. a change) in the packaging material and the notification of change involved.
The scope of data on a packaging material necessary to obtain a
marketing authorisation for a medicinal product follows from a decision
tree in Appendix II. This tree shows that only few data are required for
plastic packaging materials for solid dosage forms (general information,
specification). In contrast to this, additional data (going as far as
extraction studies, interaction studies and toxicological information) are
needed for plastic packaging materials for inhalants, parenterals and
Pharmaceutical packaging materials are also the focus of two interesting
events offered by the European Compliance Academy in the next few months:
Exctractables and Leachables Testing
The detailed document can be found here.